Casdin Capital’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-125,000
| Closed | -$171K | – | 42 |
|
|
2025
Q1 | $171K | Sell |
125,000
-1,063,349
| -89% | -$1.46M | 0.01% | 43 |
|
|
2024
Q4 | $3.67M | Hold |
1,188,349
| – | – | 0.24% | 31 |
|
|
2024
Q3 | $9.15M | Hold |
1,188,349
| – | – | 0.61% | 23 |
|
|
2024
Q2 | $10.2M | Hold |
1,188,349
| – | – | 0.78% | 23 |
|
|
2024
Q1 | $9.44M | Hold |
1,188,349
| – | – | 0.7% | 25 |
|
|
2023
Q4 | $11.8M | Sell |
1,188,349
-119,000
| -9% | -$1.18M | 1.15% | 19 |
|
|
2023
Q3 | $14.7M | Buy |
1,307,349
+307,349
| +31% | +$3.46M | 1.63% | 17 |
|
|
2023
Q2 | $3.32M | Hold |
1,000,000
| – | – | 0.29% | 33 |
|
|
2023
Q1 | $3.95M | Buy |
+1,000,000
| New | +$3.95M | 0.33% | 35 |
|
|
2022
Q3 | – | Sell |
-3,500,000
| Closed | -$15.9M | – | 43 |
|
|
2022
Q2 | $15.9M | Sell |
3,500,000
-1,987,910
| -36% | -$9.01M | 1.34% | 21 |
|
|
2022
Q1 | $41.6M | Hold |
5,487,910
| – | – | 1.87% | 23 |
|
|
2021
Q4 | $60M | Hold |
5,487,910
| – | – | 1.69% | 21 |
|
|
2021
Q3 | $71M | Buy |
+5,487,910
| New | +$71M | 1.77% | 24 |
|